Target intelligence / Profile preview

MicroRNA 3919 (miR-3919)

Target
miR-3919
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 3919 (miR-3919) is a small, non-coding RNA molecule that belongs to the microRNA family and functions in the post-transcriptional regulation of gene expression. It has been characterized as a potential tumor suppressor: in prostate cancer, overexpression of miR-3919 inhibited cellular proliferation, migration, and invasion while promoting apoptosis, partly through direct repression of the oncogenic gene DJ-1. In vivo, miR-3919 overexpression led to reduced tumor growth in xenograft models. Additionally, miR-3919 is consistently overexpressed in high-grade B-cell lymphoma with 11q aberration, suggesting its value as a diagnostic biomarker for this subtype, and has been detected in other aggressive B-cell tumors. Though its expression and pathogenic relevance in various epithelial cancers are emerging, its functional role in other biological or pathological processes remains under investigation. Targeting the miR-3919/DJ-1 axis may represent a new therapeutic avenue for prostate cancer and potentially for other malignancies characterized by aberrant DJ-1 activity or miR-3919 expression

Other names
hsa-mir-3919MIR3919miR-3919
02

Mechanism of action

Regulation of oncogenic genes (e.g. DJ-1) by post-transcriptional repression; Tumor-suppressive action via miR-3919/DJ-1 axis

03

Biological functions

Regulation of gene expressionApoptosisCell proliferationInhibition of cell migration and invasionTumor suppression (in prostate cancer and potentially certain lymphomas)
04

Disease associations

Cancer (notably prostate cancer, aggressive B-cell lymphomas)Other (potential involvement in other epithelial tumors)
05

Safety considerations

Unknown/insufficient data; no notable safety concerns or therapeutic challenges specifically identified for targeting miR-3919 to date
06

Interacting drugs

Sulforaphane (SFN)
07

Biomarkers

miR-3919 expression as a diagnostic biomarker for high-grade B-cell lymphoma with 11q aberration (HGBCL-11q)Lower miR-3919 expression as marker of prostate cancer versus adjacent tissue

Beyond the preview

Go deeper on MicroRNA 3919 (miR-3919).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3919 (miR-3919).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call